Published April 28, 2026
| Version v1
Preprint
Open
Complement C3a receptor antagonism for ME/CFS neuroinflammation
Description
Complement component 3a receptor (C3AR1) is activated by elevated C3a levels in ME/CFS patients, triggering microglial activation and neuroinflammation in brain regions controlling fatigue and cognitive function. C3AR1 antagonists like SB290157 or PMX205 could reduce complement-mediated neuroinflammation and improve central nervous system symptoms.
Notes
Files
hypothesis.json
Files
(347 Bytes)
| Name | Size | Download all |
|---|---|---|
|
md5:1c44d6fab4202e58592437c944de3dc0
|
347 Bytes | Preview Download |